Clinical trials: Hypofractionation
Prostate Adenocarcinoma
ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma
This study will determine the delayed neurotoxicity (12 months) of a hypofractionated high dose irradiation (3 Gy x 9) associated with zoledronic acid.
- Trial name
- GEMO (NCT01219790)
- Testing
- external radiotherapy, Acide zoledronic
- Where
- 3 sites in France
- Volunteers
- 30 people
- Sponsor
- Institut Cancerologie de l'Ouest
Breast Cancer
Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery
This is a retrospective study on evaluation of the efficacy and the safety of a hypofractionated radiotherapy course with weekly concomitant boost for breast cancer patients treated with conservative breast surgery .
- Trial name
- NCT04815642
- Testing
- radiotherapy
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Assiut University
Breast Cancer
Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer
Post-operative loco-regional (LR) hypofractionated radiotherapy (Hypo-RT) is an attractive approach in locally advanced breast cancer (LABC).
- Trial name
- HIPOMAMMLINF (NCT04792346)
- Testing
- breast/chest wall radiotherapy
- Where
- Italy
- Volunteers
- 61 people
- Sponsor
- Regina Elena Cancer Institute